<VariationArchive RecordType="classified" VariationID="35545" VariationName="NC_000008.11:g.(?_18051554)_(18107050_?)del" VariationType="Deletion" Accession="VCV000035545" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2015-07-16" MostRecentSubmission="2015-07-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="44216" VariationID="35545">
      <GeneList>
        <Gene Symbol="ASAH1" FullName="N-acylsphingosine amidohydrolase 1" GeneID="427" HGNC_ID="HGNC:735" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>8p22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="18055992" stop="18084961" display_start="18055992" display_stop="18084961" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="17913924" stop="17942506" display_start="17913924" display_stop="17942506" Strand="-" />
          </Location>
          <OMIM>613468</OMIM>
        </Gene>
        <Gene Symbol="ASAH1-AS1" FullName="ASAH1 antisense RNA 1" GeneID="101929066" HGNC_ID="HGNC:55603" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>8p22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="18084868" stop="18097651" display_start="18084868" display_stop="18097651" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="17942535" stop="17953415" display_start="17942535" display_stop="17953415" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129999939" FullName="ATAC-STARR-seq lymphoblastoid active region 27051" GeneID="129999939" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>8p22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="18083564" stop="18083673" display_start="18083564" display_stop="18083673" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129999940" FullName="ATAC-STARR-seq lymphoblastoid silent region 18966" GeneID="129999940" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>8p22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="18084024" stop="18084223" display_start="18084024" display_stop="18084223" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000008.11:g.(?_18051554)_(18107050_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8p22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" innerStart="18051554" innerStop="18107050" display_start="18051554" display_stop="18107050" variantLength="55497" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" innerStart="17909063" innerStop="17964559" display_start="17909063" display_stop="17964559" variantLength="55497" />
      </Location>
      <OtherNameList>
        <Name>ASAH1, DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.(?_17909063)_(17964559_?)del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.(?_17909063)_(17964559_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.(?_18051554)_(18107050_?)del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.(?_18051554)_(18107050_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="613468.0007" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000008.11:g.(?_18051554)_(18107050_?)del AND Spinal muscular atrophy-progressive myoclonic epilepsy syndrome" Accession="RCV000029200" Version="4">
        <ClassifiedConditionList TraitSetID="8719">
          <ClassifiedCondition DB="MedGen" ID="C1834569">Spinal muscular atrophy-progressive myoclonic epilepsy syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2012-07-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2012-07-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2015-07-16" MostRecentSubmission="2015-07-16">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22703880</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8719" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5587" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MYOCLONUS, HEREDITARY, WITH PROGRESSIVE DISTAL MUSCULAR ATROPHY</ElementValue>
                <XRef Type="MIM" ID="159950" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY</ElementValue>
                <XRef Type="MIM" ID="159950" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613468.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613468.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613468.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="613468.0010" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Jankovic Rivera syndrome</ElementValue>
                <XRef ID="Jankovic+Rivera+syndrome/3897" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary myoclonus and progressive distal muscular atrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Spinal muscular atrophy-progressive myoclonic epilepsy syndrome</ElementValue>
                <XRef ID="MONDO:0008045" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SMAPME</ElementValue>
                <XRef Type="MIM" ID="159950" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of ASAH1-related disorders ranges from Farber disease (FD) to spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME). Classic FD is characterized by onset in the first weeks of life of painful, progressive deformity of the major joints; palpable subcutaneous nodules of joints and mechanical pressure points; and a hoarse cry resulting from granulomas of the larynx and epiglottis. Life expectancy is usually less than two years. In the other less common types of FD, onset, severity, and primary manifestations vary. SMA-PME is characterized by early-childhood-onset progressive lower motor neuron disease manifest typically between ages three and seven years as proximal lower-extremity weakness, followed by progressive myoclonic and atonic seizures, tremulousness/tremor, and sensorineural hearing loss. Myoclonic epilepsy typically begins in late childhood after the onset of weakness and can include jerking of the upper limbs, action myoclonus, myoclonic status, and eyelid myoclonus. Other findings include generalized tremor, and cognitive decline. The time from disease onset to death from respiratory complications is usually five to 15 years.</Attribute>
                <XRef ID="NBK488189" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3875" />
                <XRef ID="3875" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29595935</ID>
                <ID Source="BookShelf">NBK488189</ID>
              </Citation>
              <XRef ID="2590" DB="Orphanet" />
              <XRef ID="C1834569" DB="MedGen" />
              <XRef ID="MONDO:0008045" DB="MONDO" />
              <XRef Type="MIM" ID="159950" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="55943" SubmissionDate="2015-07-13" DateLastUpdated="2015-07-16" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="613468.0007_SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY" title="ASAH1, DEL_SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY" />
        <ClinVarAccession Accession="SCV000051845" DateUpdated="2015-07-16" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-07-13">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of deletion of the ASAH1 gene that was found in compound heterozygous state in a patient with spinal muscular atrophy with progressive myoclonic epilepsy (SMAPME; 159950) by Zhou et al. (2012), see 613468.0006.</Attribute>
              <Citation>
                <ID Source="PubMed">22703880</ID>
              </Citation>
              <XRef DB="OMIM" ID="159950" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASAH1" />
          </GeneList>
          <Name>ASAH1, DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="613468.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="55943" TraitType="Disease" MappingType="Name" MappingValue="SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY" MappingRef="Preferred">
        <MedGen CUI="C1834569" Name="Spinal muscular atrophy-progressive myoclonic epilepsy syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

